These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27067285)

  • 21. Dehydroepiandrosterone (DHEA) supplementation for cognitive function .
    Huppert FA; Van Niekerk JK
    Cochrane Database Syst Rev; 2001; (2):CD000304. PubMed ID: 11405958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Dehydroepiandrosterone (DHEA) Supplementation on IVF or ICSI: A Meta-Analysis of Randomized Controlled Trials.
    Xu L; Hu C; Liu Q; Li Y
    Geburtshilfe Frauenheilkd; 2019 Jul; 79(7):705-712. PubMed ID: 31303658
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of dehydroepiandrosterone supplementation during stressful military training: a randomized, controlled, double-blind field study.
    Taylor MK; Padilla GA; Stanfill KE; Markham AE; Khosravi JY; Ward MD; Koehler MM
    Stress; 2012 Jan; 15(1):85-96. PubMed ID: 21790446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916).
    Safdarian L; Mohammadi FS; Alleyassin A; Aghahosseini M; Meysamie A; Rahimi E
    Hum Reprod; 2007 Sep; 22(9):2449-54. PubMed ID: 17635844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
    von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
    Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial.
    van Vollenhoven RF; Engleman EG; McGuire JL
    Arthritis Rheum; 1995 Dec; 38(12):1826-31. PubMed ID: 8849355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are intracytoplasmic sperm injection and high serum estradiol compounding risk factors for adverse obstetric outcomes in assisted reproductive technology?
    Royster GD; Krishnamoorthy K; Csokmay JM; Yauger BJ; Chason RJ; DeCherney AH; Wolff EF; Hill MJ
    Fertil Steril; 2016 Aug; 106(2):363-370.e3. PubMed ID: 27172401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial.
    Jankowski CM; Gozansky WS; Schwartz RS; Dahl DJ; Kittelson JM; Scott SM; Van Pelt RE; Kohrt WM
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders.
    Yeung T; Chai J; Li R; Lee V; Ho PC; Ng E
    BJOG; 2016 Jun; 123(7):1097-105. PubMed ID: 26663817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial.
    Binder G; Weber S; Ehrismann M; Zaiser N; Meisner C; Ranke MB; Maier L; Wudy SA; Hartmann MF; Heinrich U; Bettendorf M; Doerr HG; Pfaeffle RW; Keller E;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1182-90. PubMed ID: 19126625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults.
    Lin H; Li L; Wang Q; Wang Y; Wang J; Long X
    Gynecol Endocrinol; 2019 Nov; 35(11):924-931. PubMed ID: 31237150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial.
    Nachshoni T; Ebert T; Abramovitch Y; Assael-Amir M; Kotler M; Maayan R; Weizman A; Strous RD
    Schizophr Res; 2005 Nov; 79(2-3):251-6. PubMed ID: 16126372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis.
    Xiong Y; Bu Z; Dai W; Zhang M; Bao X; Sun Y
    Reprod Biol Endocrinol; 2014 Nov; 12():109. PubMed ID: 25420965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial.
    Strous RD; Stryjer R; Maayan R; Gal G; Viglin D; Katz E; Eisner D; Weizman A
    Psychoneuroendocrinology; 2007 Feb; 32(2):96-105. PubMed ID: 17208382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserve and is a potential regulator of the immune response in the ovaries.
    Zhang J; Qiu X; Gui Y; Xu Y; Li D; Wang L
    Biosci Trends; 2015 Dec; 9(6):350-9. PubMed ID: 26781792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
    van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL
    Lupus; 1999; 8(3):181-7. PubMed ID: 10342710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial.
    Bassiouny YA; Dakhly DMR; Bayoumi YA; Hashish NM
    Fertil Steril; 2016 Mar; 105(3):697-702. PubMed ID: 26690008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial.
    Rice SP; Agarwal N; Bolusani H; Newcombe R; Scanlon MF; Ludgate M; Rees DA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1966-72. PubMed ID: 19318448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.